Drug profile · INN
acamprosate
CAMPRAL
acamprosate (CAMPRAL) is a gaba-a receptor; anion channel positive modulator. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — acamprosate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
acamprosate (CAMPRAL) is a gaba-a receptor; anion channel positive modulator. Associated with Alphapharm Pty Ltd.
Key facts
INN acamprosate
Brand CAMPRAL
Mechanism GABA-A receptor; anion channel positive modulator
Originator Alphapharm Pty Ltd
Mechanism of action
GABA-A receptor; anion channel positive modulator
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is acamprosate?
acamprosate (CAMPRAL) is a gaba-a receptor; anion channel positive modulator. Associated with Alphapharm Pty Ltd.
What is the brand name for acamprosate?
CAMPRAL is a marketed brand name for acamprosate. Check FDA Drugs@FDA for the current US label holder and prescribing information.